id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-345040-cuau2dcy	Alom, Samiha	Use of ECMO in COVID-19 patients: Does the evidence suffice?	2020-07-30		.txt	text/plain	2704	152	47	In March 2020, the World Health Organisation (WHO) released interim guidelines that advocate the use of extracorporeal membrane oxygenation (ECMO) to support the cardiorespiratory system in patients who fail maximal conventional therapies with ARDS [4] . We have performed a comprehensive electronic literature search following 'Preferred Reporting Items for Systematic Reviews and Metaanalysis' (PRISMA) guidelines and using key words 'COVID-19' 'SARS-CoV2' 'Coronavirus' 'ECMO' 'Extracorporeal membrane oxygenation' 'VA-ECMO' 'VV-ECMO' 'Outcomes' 'Respiratory support' 'circulatory support' either as MeSH terms or in the combined key-word formats. According to a systematic review and meta-analysis which included the CESAR [31] and EOLIA [32] trials amongst others, the use of VV-ECMO in acute severe respiratory failure was associated with a 60-day reduced mortality (RR 0.73, 95% CI 0.58-0.92) when compared with conventional mechanical ventilation [33] . Successful COVID-19 rescue therapy by extracorporeal membrane oxygenation (ECMO) for respiratory failure: a case report	./cache/cord-345040-cuau2dcy.txt	./txt/cord-345040-cuau2dcy.txt